Although the activation of TGF‐β signaling and EGFR overexpression are often observed in invasive breast carcinomas and correlated with cancer progression (Katz et al., 2013; Masuda et al., 2012), the detailed mechanism remains unclear. The gene discussed is TGFB1; the disease is cancer.